154 related articles for article (PubMed ID: 36999902)
1. GeNeo: A Bioinformatics Toolbox for Genomics-Guided Neoepitope Prediction.
Al Seesi S; Al-Okaily A; Shcheglova TV; Sherafat E; Alqahtani FH; Hagymasi AT; Kaur A; Srivastava PK; Măndoiu II
J Comput Biol; 2023 Apr; 30(4):538-551. PubMed ID: 36999902
[TBL] [Abstract][Full Text] [Related]
2. Population-level distribution and putative immunogenicity of cancer neoepitopes.
Wood MA; Paralkar M; Paralkar MP; Nguyen A; Struck AJ; Ellrott K; Margolin A; Nellore A; Thompson RF
BMC Cancer; 2018 Apr; 18(1):414. PubMed ID: 29653567
[TBL] [Abstract][Full Text] [Related]
3. Computational Methods for Identification of T Cell Neoepitopes in Tumors.
Jurtz VI; Olsen LR
Methods Mol Biol; 2019; 1878():157-172. PubMed ID: 30378075
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics for Cancer Immunotherapy.
Holtsträter C; Schrörs B; Bukur T; Löwer M
Methods Mol Biol; 2020; 2120():1-9. PubMed ID: 32124308
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics workflows for clinical applications in precision oncology.
Jäger N
Semin Cancer Biol; 2022 Sep; 84():103-112. PubMed ID: 33476720
[TBL] [Abstract][Full Text] [Related]
6. The neoepitope landscape of breast cancer: implications for immunotherapy.
Narang P; Chen M; Sharma AA; Anderson KS; Wilson MA
BMC Cancer; 2019 Mar; 19(1):200. PubMed ID: 30832597
[TBL] [Abstract][Full Text] [Related]
7. Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery.
de Sousa E; Lérias JR; Beltran A; Paraschoudi G; Condeço C; Kamiki J; António PA; Figueiredo N; Carvalho C; Castillo-Martin M; Wang Z; Ligeiro D; Rao M; Maeurer M
Front Immunol; 2021; 12():592031. PubMed ID: 34335558
[TBL] [Abstract][Full Text] [Related]
8. Semi-supervised learning for somatic variant calling and peptide identification in personalized cancer immunotherapy.
Sherafat E; Force J; Măndoiu II
BMC Bioinformatics; 2020 Dec; 21(Suppl 18):498. PubMed ID: 33375939
[TBL] [Abstract][Full Text] [Related]
9. AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting.
Wünsch C; Banck H; Müller-Tidow C; Dugas M
BMC Med Genomics; 2020 Feb; 13(1):17. PubMed ID: 32019565
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of neoepitope landscapes for adult and pediatric cancers.
Feng YY; Griffith OL; Griffith M
Genome Med; 2017 Aug; 9(1):77. PubMed ID: 28854952
[TBL] [Abstract][Full Text] [Related]
11. The neoepitope landscape in pediatric cancers.
Chang TC; Carter RA; Li Y; Li Y; Wang H; Edmonson MN; Chen X; Arnold P; Geiger TL; Wu G; Peng J; Dyer M; Downing JR; Green DR; Thomas PG; Zhang J
Genome Med; 2017 Aug; 9(1):78. PubMed ID: 28854978
[TBL] [Abstract][Full Text] [Related]
12. NeoMutate: an ensemble machine learning framework for the prediction of somatic mutations in cancer.
Anzar I; Sverchkova A; Stratford R; Clancy T
BMC Med Genomics; 2019 May; 12(1):63. PubMed ID: 31096972
[TBL] [Abstract][Full Text] [Related]
13. ProTECT-Prediction of T-Cell Epitopes for Cancer Therapy.
Rao AA; Madejska AA; Pfeil J; Paten B; Salama SR; Haussler D
Front Immunol; 2020; 11():483296. PubMed ID: 33244314
[TBL] [Abstract][Full Text] [Related]
14. In silico tools and databases for designing cancer immunotherapy.
Dhall A; Jain S; Sharma N; Naorem LD; Kaur D; Patiyal S; Raghava GPS
Adv Protein Chem Struct Biol; 2022; 129():1-50. PubMed ID: 35305716
[TBL] [Abstract][Full Text] [Related]
15. Variant Review with the Integrative Genomics Viewer.
Robinson JT; Thorvaldsdóttir H; Wenger AM; Zehir A; Mesirov JP
Cancer Res; 2017 Nov; 77(21):e31-e34. PubMed ID: 29092934
[TBL] [Abstract][Full Text] [Related]
16. Studying cancer genomics through next-generation DNA sequencing and bioinformatics.
Doyle MA; Li J; Doig K; Fellowes A; Wong SQ
Methods Mol Biol; 2014; 1168():83-98. PubMed ID: 24870132
[TBL] [Abstract][Full Text] [Related]
17. PipeIT: A Singularity Container for Molecular Diagnostic Somatic Variant Calling on the Ion Torrent Next-Generation Sequencing Platform.
Garofoli A; Paradiso V; Montazeri H; Jermann PM; Roma G; Tornillo L; Terracciano LM; Piscuoglio S; Ng CKY
J Mol Diagn; 2019 Sep; 21(5):884-894. PubMed ID: 31229654
[TBL] [Abstract][Full Text] [Related]
18. The Architecture of a Precision Oncology Platform.
Laganà A
Adv Exp Med Biol; 2022; 1361():1-22. PubMed ID: 35230680
[TBL] [Abstract][Full Text] [Related]
19. Detection of oncogenic and clinically actionable mutations in cancer genomes critically depends on variant calling tools.
Garcia-Prieto CA; Martínez-Jiménez F; Valencia A; Porta-Pardo E
Bioinformatics; 2022 Jun; 38(12):3181-3191. PubMed ID: 35512388
[TBL] [Abstract][Full Text] [Related]
20. Genomics-Guided Immunotherapy for Precision Medicine in Cancer.
Mukherjee S
Cancer Biother Radiopharm; 2019 Oct; 34(8):487-497. PubMed ID: 31314580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
